All 1 tracked stories fall under one category: corporate-law. Johnson & Johnson is most often covered alongside Chris Seeger, which appears in 1 of these 1 story. Each carries 3 original sources on average. We currently track 1 Legal story that mention Johnson & Johnson, all published on July 28, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Johnson & Johnson
All 1 tracked stories fall under one category: corporate-law. Johnson & Johnson is most often covered alongside Chris Seeger, which appears in 1 of these 1 story. Each carries 3 original sources on average. We currently track 1 Legal story that mention Johnson & Johnson, all published on July 28, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 9 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Johnson & Johnson. Shared-story counts are live from our verified record — not editorial picks.
The $5.5B proposal to resolve 76,000 ovarian cancer talc lawsuits represents a strategic retreat for J&J, contingent on 95% claimant approval and following failed bankruptcy attempts.
Johnson & Johnson is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.